Cardioprotective effects of sodium-glucose transport protein 2 inhibitors in patients with breast cancer and concomitant type 2 diabetes mellitus undergoing chemotherapy
Background. Breast cancer continues to be the most frequently diagnosed malignancy among women globally, with millions of new cases identified each year. Despite significant advances in chemotherapy that have considerably enhanced survival rates, these improvements are often accompanied by adverse e...
Saved in:
| Main Authors: | S.V. Fedorov, S.B. Herashchenko, I.V. Kozlova, M.V. Bielinskyi, A.S. Herashchenko, H.D. Roiko, S.A. Vahyl |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zaslavsky O.Yu.
2025-05-01
|
| Series: | Mìžnarodnij Endokrinologìčnij Žurnal |
| Subjects: | |
| Online Access: | https://iej.zaslavsky.com.ua/index.php/journal/article/view/1535 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sodium Glucose Transporter 2 Inhibitor Protects Against Heart Failure With Preserved Ejection Fraction: Preclinical “2‐Hit” Model Reveals Autophagy Enhancement Via AMP‐Activated Protein Kinase/Mammalian Target of Rapamycin Complex 1 Pathway
by: Xinyu Hu, et al.
Published: (2025-08-01) -
Comparative analysis of cardioprotective effects of two renal denervation techniques
by: T. M. Ripp, et al.
Published: (2020-12-01) -
Prognostic Significance of Echocardiographic Characteristics in Patients with Type 2 Myocardial Infarction: comparison with Type 1 Myocardial Infarction
by: T. H. Hoang, et al.
Published: (2023-11-01) -
Effect of Sodium-Glucose Cotransporter Type 2 Inhibitors on The Development and Course of Atrial Fibrillation
by: D. A. Ishmaev, et al.
Published: (2025-01-01) -
Some Morpho-Functional Changes of the Left Heart in Patients with Viral Liver Cirrhosis
by: M V. Chistyakova, et al.
Published: (2018-09-01)